WEBULL
WebtradeDownload

Ducommun (DCO) Stock Slips As Margin Gains Clash With Restatement Risk

Simply Wall St · 1d ago

Ducommun stock slipped about 2% today, even though the company just printed one of its cleanest profit stories in years. Revenue for Q2 2026 came in at US$224.5m with adjusted earnings per share of US$1.18 and gross margin at 28%. For an aerospace and defense supplier, that margin profile and the record US$1.16b backlog are what really matter. The near term price move suggests traders are cautious, while the multi year setup indicates a business leaning on higher quality engineered content and a thicker order book.

Is Ducommun stock quietly pricing in a genuine earnings turnaround, or just giving you a value trap with better margins? Compare the current P/S and DCF gap against our valuation analysis for Ducommun.

Q2 2026 Earnings Summary

  • Revenue, Q2 2026 vs. Q2 2025: US$224.5m vs. US$200.8m (up about 12%)
  • Net Income, Q2 2026 vs. Q2 2025: US$20.4m vs. US$12.8m (up about 60%)
  • Basic EPS, Q2 2026 vs. Q2 2025: US$1.35 vs. US$0.85 (up about 58%)
  • Gross Margin, Q2 2026: 28% (management highlighted continued margin expansion)

Prefer clean charts instead of another wall of dense earnings tables and footnotes? See Ducommun's overall valuation picture in an easy visual format in the full company report for Ducommun.

NYSE:DCO Trailing 12-Month Revenue & Expenses Breakdown as at Aug 2026
NYSE:DCO Trailing 12-Month Revenue & Expenses Breakdown as at Aug 2026

Ducommun bull case: missiles, mix and margins on test

The optimistic view says Ducommun is becoming a higher margin missile and engineered content supplier with rising earnings power. Q2 gives the bull camp real milestones. Missile revenue in Military & Space was up 68% in the quarter and 29% over 12 months, and missiles, radar and electronic warfare now represent about 35% of defense revenue and more than 20% of total revenue. That supports the claim that growth is shifting to higher value programs. Gross margin at 28% and adjusted EBITDA margin at 17.1% are close to the 18% Vision 2027 target that management reaffirmed. Record backlog of US$1.16b with a roughly 1.3 to 1.4x book to bill ratio also lines up with the idea of a thicker, higher quality order book, not just a short spike in demand.

Bear case: execution, governance and earnings quality concerns

The cautious view argues Ducommun needs almost flawless execution and that governance and backlog issues could cap upside. Q2 does not erase those worries. The company is still restating 2024 and 2025 financials, and an investor investigation is underway, so accounting and governance risk remains live despite strong current margins. Prior research flagged a roughly 16% backlog decline over two years and weaker operating margin and returns on invested capital. The record US$1.16b backlog and better profitability show progress against that history, but do not yet prove it resolved. Management also guided to more muted second half growth after pulling some production into H1, which supports the bear concern that part of the recent strength is timing related rather than a smooth earnings ramp. The 2.2% share price drop on the day hints that investors are still weighing these risks carefully.

Access the analyst estimates for Ducommun to see where the consensus models start to disagree on Ducommun's revenue, margin and EPS path, and whether the current share price move is masking a much sharper inflection point in the next few fiscal years.

Stay Ahead With Simply Wall St

If Ducommun's margin profile and backlog shift have caught your attention, register for free with Simply Wall St and add it to your Watchlist to track price against fair value and watch how the story develops from here. Once you decide to take a position, keep on top of what matters with the Portfolio Command Center that cuts through noise and highlights the updates that could move your thesis. Over the longer term, compare your view on Ducommun with thousands of other investors through the Community and see what the market might be missing. By surfacing hidden catalysts and risks early, you give yourself a better chance to react before the crowd and stay ahead of the market.

Seeking Alternatives Beyond Ducommun Stock?

Fresh ideas move first and slow research lags behind. Spot companies building breakout momentum while they are still under the radar for now. Act now.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.